Structure-Based Virtual Screening to Identify Novel Potential Compound as an Alternative to Remdesivir to Overcome the RdRp Protein Mutations in SARS-CoV-2

The number of confirmed COVID-19 cases is rapidly increasing with no direct treatment for the disease. Few repurposed drugs, such as Remdesivir, Chloroquine, Hydroxychloroquine, Lopinavir, and Ritonavir, are being tested against SARS-CoV-2. Remdesivir is the drug of choice for Ebola virus disease an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar D, Thirumal, Shaikh, Nishaat, Kumar S, Udhaya, Doss C, George Priya, Zayed, Hatem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062963/
https://www.ncbi.nlm.nih.gov/pubmed/33898520
http://dx.doi.org/10.3389/fmolb.2021.645216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062963/
https://www.ncbi.nlm.nih.gov/pubmed/33898520
http://dx.doi.org/10.3389/fmolb.2021.645216

Ejemplares similares